Phase 2 Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 75 years of age, of any gender
- People whose tumor is located in the colon, where the bottom edge of the tumor is more than 12 cm away from the anus
- People who have already had surgery to remove the tumor, and whose cancer was confirmed by laboratory testing to be at stage III (meaning it spread to nearby lymph nodes but not to other parts of the body)
- People whose recent scans show no signs of the cancer coming back or spreading
- People who are generally well enough to carry out light activity and care for themselves (a fitness level rated 0 or 1 on a standard medical scale)
- People whose blood counts, kidney function, and liver function meet the minimum levels required by the trial (confirm specific values with the trial site)
- People with no history of allergic reactions to a class of chemotherapy drugs called fluoropyrimidines or platinum-based drugs
- People who are willing to participate, sign a consent form, and attend follow-up appointments as required
Who may not be able to join:
- People who have had another type of cancer in the past five years, with the exception of certain skin cancers or early-stage cervical cancer that was treated with curative surgery
- People whose tumor has a specific gene change known as a BRAF mutation
- People whose tumor has features called microsatellite instability-high (MSI-H) or deficient mismatch repair (dMMR) — these are characteristics identified through laboratory testing of the tumor tissue (confirm with trial site)
- People who have already received chemotherapy, radiation, targeted therapy, or immunotherapy for their colon cancer
- People who may have a hereditary condition called Lynch syndrome
- People with serious heart, blood vessel, brain, liver, kidney, or blood disorders
- People with severe mental health conditions
- People whose current situation may make it unsafe or difficult to participate, including those with a current need or plan to become pregnant, people who are pregnant or breastfeeding, or people with conditions such as depression, bipolar disorder, obsessive-compulsive disorder, or schizophrenia
- People who are currently taking part in, or have recently taken part in, another clinical drug trial
- People considered unsuitable for the trial by the treating doctor, for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8685422480
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in value of ctDNA concentration
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.